Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
Clinical trial NCT00262730 · COMPLETED
Trial details
- NCT number
- NCT00262730
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2009-08-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.